Our results identified four PDA subtypes with the presence of at least two cancer metabolic vulnerabilities linked to glycolytic pathway: one related to the dependency of specific transcriptional regulators like FoxM1, the other one related to the metabolic flow redirection toward fatty acid elongation instead of oxidative phosphorylation. This evidence concerns the gene FOXM1 and Patent ductus arteriosus.